Since its inception in 1992, Medeia Inc. has been at the forefront of the manufacture and distribution of neurodiagnostic and heart rate variability/ANS products. Medeia Inc. specializes in the development of state-of-the-art biometrical software and hardware products intended to monitor physiology for research and educational purposes. Read More
argenx is a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases. Partnering with leading academic researchers through its Immunology Innovation Program (IIP), argenx aims to translate immunology breakthroughs into a world-class portfolio of novel antibody-based medicines. argenx developed and is commercializing the first approved neonatal Fc receptor (FcRn) […] Read More
Axsome Therapeutics is a biopharmaceutical company leading a new era in the treatment of central nervous system (CNS) conditions. Axsome delivers scientific breakthroughs by identifying critical gaps in care and develop differentiated products with a focus on novel mechanisms of action that enable meaningful advancements in patient outcomes. Their industry-leading neuroscience portfolio includes FDA-approved treatments […] Read More